Repository logo
  • English
  • Italiano
  • Log In
    Have you forgotten your password?
Repository logo
Repository logo
  • Archive
  • Series/Journals
  • EUT
  • Events
  • Statistics
  • English
  • Italiano
  • Log In
    Have you forgotten your password?
  1. Home
  2. EUT Edizioni Università di Trieste
  3. Atti di convegni
  4. Trans2Care
  5. Trans2Care, 2014. Cross-Border Italy-Slovenia Biomedical Research. Are we ready for Horizon 2020?
  6. Nano-immuno assay development for the detection of cancer biomarkers
 
  • Details
  • Metrics
Options

Nano-immuno assay development for the detection of cancer biomarkers

Ambrosetti, Elena
•
Bosco, Alessandro
•
Casalis, Loredana
2014
Loading...
Thumbnail Image
ISBN
978-88-8303-572-2
http://hdl.handle.net/10077/10271
  • Book Chapter

e-ISBN
978-88-8303-573-9
Abstract
The quantitative analysis of protein markers is a promising strategy in diagnosis, prognosis and therapy monitoring of malignant tumors. The optimization of the clinical detection of these markers is directed towards the use of a small volume system. We developed a multiplexing nano-immuno array for proteomic analysis in low sample volumes with potential capability of pathological screening of cancer biomarkers. Nanografting, a tip assisted Atomic Force Microscopy (AFM) nanolithography technique is used to fabricate DNA nanoarrays. DNA nanospots created by nanografting are exploited in order to immobilize DNA-antibody conjugates that recognize specific proteins of interest. The determination of the antigen content of a biological sample was obtained from the analysis of AFM topographic profiles of the nanopatches before and after the incubation. As a proof of principle, we focused on the biomarker Human Epidermal Growth Factor Receptor 2 (Her2), relevant antigen found in some human cancers such as breast, lung and gastric ones. By measuring spot height variation we performed the detection of low concentrations of the biomarker and we were able to optimize the device sensitivity by correlating the density of the DNA-antibody conjugates on the surface and their capability to bind the Extra Cellular Domain (ECD) of Her2. As future perspectives we are also exploring the use of new binders, as aptamers and nanobodies (VHH), as new tool for the recognition of specific biomarkers with higher affinity.
Subjects
  • AFM

  • nano-immuno assay

  • cancer biomarker

Publisher
EUT Edizioni Università di Trieste
Source
Elena Ambrosetti, Alessandro Bosco, Loredana Casalis, Nano-immuno assay development for the detection of cancer biomarkers, in S. Passamonti, S. Gustincich, T. Lah Turnšek, B. Peterlin, R. Pišot, P. Storici (Eds.), Cross-border Italy-Slovenia biomedical research: are we ready for horizon 2020? Conference proceedings with an analysis of innovation management and knowledge transfer potential for a smart specialization strategy. Trieste, EUT Edizioni Università di Trieste, 2014, pp. 111-114
Languages
en
File(s)
Loading...
Thumbnail Image
Download
Name

Elena Ambrosetti.pdf

Format

Adobe PDF

Size

473.43 KB

Indexed by

 Info

Open Access Policy

Share/Save

 Contacts

EUT Edizioni Università di Trieste

OpenstarTs

 Link

Wiki OpenAcces

Archivio Ricerca ArTS

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback